Authors: Astuti, D Agathanggelou, A Honorio, S Dallol, A Martinsson, T Kogner, P Cummins, C Neumann, HPH Voutilainen, R Dahia, P Eng, C Maher, ER Latif, F

Citation: D. Astuti et al., RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours, ONCOGENE, 20(51), 2001, pp. 7573-7577

Authors: Agathanggelou, A Honorio, S Macartney, DP Martinez, A Dallol, A Radar, J Fullwood, P Chauhan, A Walker, R Shaw, JA Hosoe, S Lerman, MI Minna, JD Maher, ER Latif, F

Citation: A. Agathanggelou et al., Methylation associated inactivation of RASSF1A from region 3p21.3 in lung,breast and ovarian tumours, ONCOGENE, 20(12), 2001, pp. 1509-1518

Authors: Morrissey, C Martinez, A Zatyka, M Agathanggelou, A Honorio, S Astuti, D Morgan, NV Moch, H Richards, FM Kishida, T Yao, M Schraml, P Latif, F Maher, ER

Citation: C. Morrissey et al., Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma, CANCER RES, 61(19), 2001, pp. 7277-7281

Authors: Niedobitek, G Agathanggelou, A Steven, N Young, LS

Citation: G. Niedobitek et al., Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells, J CL PATH-M, 53(1), 2000, pp. 37-42

Authors: Hirano, A Longo, DL Taub, DD Ferris, DK Young, LS Eliopoulos, AG Agathanggelou, A Cullen, N Macartney, J Fanslow, WC Murphy, WJ

Citation: A. Hirano et al., Inhibition of human breast carcinoma growth by a soluble recombinant humanCD40 ligand, BLOOD, 93(9), 1999, pp. 2999-3007